VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HSTMHealthStream, Inc.
$26.73$783M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHSTMFinancials

HealthStream, Inc. (HSTM) Financials

27Y historyFree accessUpdated daily

Revenue growth remains consistently positive at 10.5% in 2026Q1, though operating margins remain compressed within a 3.0% to 9.9% range due to elevated operating expenses.

HSTM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Sales/Revenue311.78M304.06M291.65M279.06M266.83M256.71M244.83M254.11M231.62M247.66M225.97M209M170.69M132.27M103.73M82.07M65.75M57.4M51.6M43.95M31.78M27.36M20.06M18.2M15.79M13.5M9.65M2.6M
Revenue Growth %6.64%4.26%4.51%4.59%3.94%4.85%-3.65%9.71%-6.48%9.6%8.12%22.45%29.04%27.52%26.4%24.81%14.56%11.24%17.41%38.28%16.17%36.41%10.23%15.23%16.93%39.9%271.22%-
Cost of Goods Sold109.48M107.21M97.94M95.02M91.14M91.03M89.33M103.89M96.01M106M96.63M89.39M74.14M55.6M41.66M31.07M24.19M21.34M19.65M16.16M10.87M9.75M7.28M6.27M5.97M5.77M-2.64M1.7M
COGS % of Revenue-35.26%33.58%34.05%34.16%35.46%36.49%40.88%41.45%42.8%42.76%42.77%43.44%42.04%40.16%37.85%36.79%37.19%38.09%36.78%34.2%35.62%36.28%34.45%37.81%42.75%-27.3%65.38%
Gross Profit202.3M196.85M193.71M184.04M175.68M165.68M155.49M150.22M135.6M141.66M129.34M119.62M96.55M76.67M62.07M51M41.56M36.05M31.95M27.79M20.91M17.61M12.78M11.93M9.82M7.73M12.29M900K
Gross Margin %64.89%64.74%66.42%65.95%65.84%64.54%63.51%59.12%58.55%57.2%57.24%57.23%56.56%57.96%59.84%62.15%63.21%62.81%61.91%63.22%65.8%64.38%63.72%65.55%62.19%57.25%127.3%34.62%
Gross Profit Growth %-1.62%5.25%4.76%6.04%6.55%3.51%10.78%-4.28%9.53%8.13%23.9%25.92%23.51%21.71%22.7%15.28%12.86%14.97%32.86%18.74%37.82%7.15%21.47%27.01%-37.08%1265.24%-
Operating Expenses178.93M176.62M172.42M168.02M163.23M157.62M139.68M135.5M120.11M131.86M123.77M106.06M80.17M62M48.62M39.66M34.5M30.93M29.46M25.87M19.01M16.02M14.07M15.73M22.18M29.11M34.96M5.5M
OpEx % of Revenue-58.09%59.12%60.21%61.18%61.4%57.05%53.32%51.86%53.24%54.77%50.75%46.97%46.87%46.87%48.33%52.47%53.89%57.1%58.87%59.8%58.54%70.15%86.43%140.46%215.57%362.22%211.54%
Selling, General & Admin82.3M82.16M82.29M81.41M81.01M79.15M77.18M78.52M70.14M77.68M72.67M64.85M52.78M42.39M33.34M26.78M22.64M19.51M18.97M17.06M12.61M10.41M9.43M9.43M13.1M13.02M22.54M3M
SG&A % of Revenue-27.02%28.22%29.17%30.36%30.83%31.53%30.9%30.29%31.37%32.16%31.03%30.92%32.05%32.14%32.63%34.42%33.99%36.77%38.82%39.68%38.05%47.03%51.83%82.99%96.41%233.53%115.38%
Research & Development52.54M50.98M48.89M45.54M44.28M41.66M32.3M29.11M25.73M27.9M28.9M24.21M16.46M11.76M8.61M7.47M6.99M6.29M5.67M4.31M3.5M2.93M2.53M3.25M4.68M5.04M5.64M2M
R&D % of Revenue-16.77%16.76%16.32%16.59%16.23%13.2%11.46%11.11%11.26%12.79%11.59%9.64%8.89%8.3%9.11%10.63%10.95%10.99%9.8%11.02%10.7%12.62%17.85%29.63%37.33%58.43%76.92%
Other Operating Expenses4M43.48M41.24M41.08M37.95M36.81M30.19M27.87M1.08M733K581K162K146K176K118K5.41M4.88M5.14M4.82M21.56M15.5M13.09M11.54M12.48M17.5M11.05M6.78M3.5M
Operating Income23.37M20.24M21.29M16.02M12.45M8.05M15.82M14.72M15.49M9.8M5.57M13.56M16.38M14.67M13.46M11.34M7.06M5.12M2.48M1.92M1.91M1.6M-1.29M-3.8M-12.36M-21.38M-22.67M-4.6M
Operating Margin %7.5%6.66%7.3%5.74%4.67%3.14%6.46%5.79%6.69%3.96%2.46%6.49%9.59%11.09%12.97%13.82%10.74%8.92%4.81%4.36%6.01%5.84%-6.44%-20.88%-78.27%-158.31%-234.92%-176.92%
Operating Income Growth %--4.94%32.89%28.68%54.55%-49.08%7.46%-4.98%58.07%76.04%-58.94%-17.21%11.65%8.97%18.71%60.6%37.83%106.41%29.56%0.33%19.57%223.69%66.02%69.26%42.19%5.72%-392.91%-
EBITDA67.46M63.71M62.53M57.09M50.39M44.87M46.01M42.59M39.72M33.85M27.77M30.55M27.31M22.52M20.12M16.75M11.94M10.26M7.3M6.42M4.8M4.28M815.89K-751.23K-7.96M-11.44M-15.89M-4.1M
EBITDA Margin %21.64%20.95%21.44%20.46%18.89%17.48%18.79%16.76%17.15%13.67%12.29%14.62%16%17.02%19.4%20.41%18.16%17.88%14.15%14.6%15.1%15.63%4.07%-4.13%-50.44%-84.73%-164.66%-157.69%
EBITDA Growth %9.44%1.89%9.52%13.3%12.32%-2.48%8.03%7.22%17.36%21.87%-9.1%11.89%21.26%11.92%20.12%40.29%16.36%40.49%13.79%33.77%12.24%423.98%208.61%90.57%30.39%28.01%-287.62%-
D&A (Non-Cash Add-back)44.09M43.48M41.24M41.08M37.95M36.81M30.19M27.87M24.23M24.05M22.21M17M10.93M7.85M6.66M5.41M4.88M5.14M4.82M4.5M2.89M2.68M2.11M3.05M4.39M9.94M6.78M500K
EBIT24.5M23.22M21.29M16.02M12.45M8.05M15.82M14.72M15.49M9.41M6.15M13.56M16.38M14.67M13.46M11.34M7.08M5.15M2.62M1.92M1.91M1.6M-1.29M-3.8M-12.36M-21.38M-22.67M-4.6M
Net Interest Income2.82M3.34M3.83M2.36M444K000000000010K-20.86K-15.22K72.19K000000000
Interest Income2.82M3.34M3.83M2.36M444K000000000058K20.07K25.47K139.8K000000000
Interest Expense00000000000000048K40.92K40.7K67.61K000000000
Other Income/Expense2.42M2.98M3.52M2.49M3.14M-289K2M3.21M1.08M733K-372K162K146K176K118K10K-21K-15.22K72.19K226.34K618.59K337.72K242.48K3.8M12.36M-1.28M00
Pretax Income25.79M23.22M24.8M18.51M15.59M7.77M17.82M17.93M16.57M10.53M6.15M13.72M16.52M14.84M13.58M11.35M7.04M5.11M2.55M2.14M2.53M1.93M-1.05B-3.41B-16.64B-22.66M00
Pretax Margin %8.27%7.64%8.5%6.63%5.84%3.03%7.28%7.06%7.16%4.25%2.72%6.56%9.68%11.22%13.09%13.83%10.7%8.9%4.95%4.87%7.95%7.07%-5226.92%-18752.52%-105393.73%-167.8%--
Income Tax5.87M4.88M4.8M3.3M3.49M1.92M3.73M3.73M3.32M529K2.39M5.1M6.13M6.42M5.93M4.4M2.88M-8.87M-301.09K-1.95M28.04K21.5K-242.48K-386.66K4.28M-1.8M-2.39M-100K
Effective Tax Rate %22.76%21%19.34%17.82%22.42%24.74%20.94%20.82%20.05%5.02%38.92%37.16%37.09%43.28%43.69%38.81%40.98%-173.59%-11.79%-90.84%1.11%1.11%0.02%0.01%-0.03%7.95%--
Net Income19.92M18.34M20.01M15.21M12.09M5.84M14.09M15.77M32.22M10M3.75M8.62M10.39M8.42M7.64M6.94M4.15M13.97M2.85M4.09M2.5M1.91M-1.05M-3.41M-16.64M-19.58M-20.29M-4.5M
Net Margin %6.39%6.03%6.86%5.45%4.53%2.28%5.76%6.21%13.91%4.04%1.66%4.12%6.09%6.36%7.37%8.46%6.32%24.34%5.53%9.3%7.86%6.99%-5.23%-18.75%-105.39%-144.97%-210.17%-173.08%
Net Income Growth %4.22%-8.32%31.51%25.82%106.86%-58.52%-10.65%-51.05%222.04%166.42%-56.44%-17.06%23.47%10.11%10.1%67.15%-70.27%389.42%-30.15%63.51%30.67%282.47%69.27%79.5%14.99%3.5%-350.78%-
Net Income (Continuing)19.92M18.34M20.01M15.21M12.09M5.84M14.09M14.2M13.25M8.84M4.79M8.62M10.39M8.42M7.64M6.94M4.15M13.97M2.85M4.09M2.5M1.91M-1.05M-3.41M-11.64M-19.58M-20.29M-4.5M
Discontinued Operations00000001.57M18.97M1.17M000000000000000000
Minority Interest0000000000000000000000000000
EPS (Diluted)0.680.610.660.500.390.180.440.441.000.310.120.280.370.300.280.290.180.640.130.180.110.09-0.05-0.17-0.82-0.98-1.29-1.20
EPS Growth %5.6%-7.58%32%28.21%116.67%-59.09%0%-56%222.58%158.33%-57.14%-24.32%23.33%7.14%-3.45%61.11%-71.88%392.31%-27.78%63.64%22.22%276.82%70.06%79.27%16.33%24.03%-7.5%-
EPS (Basic)-0.610.660.500.390.190.440.441.000.310.120.290.380.310.290.310.190.650.130.190.120.09-0.05-0.17-0.82-0.98-1.29-1.20
Diluted Shares Outstanding29.42M30.14M30.54M30.67M30.72M31.62M31.99M32.43M32.34M32.2M32.07M30.44M28.02M27.66M27.51M23.75M22.49M21.84M22.2M22.7M22.36M21.94M20.59M20.38M20.26M19.92M15.79M3.76M
Basic Shares Outstanding29.38M30.02M30.39M30.57M30.65M31.53M31.96M32.37M32.26M31.86M31.72M30.06M27.57M26.85M26.13M22.45M21.77M21.46M21.71M22M21.58M21.05M20.59M20.38M20.26M19.92M15.79M3.76M
Dividend Payout Ratio-20.33%17.01%20.1%-0.33%0.28%0.37%100.43%-------------------

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetFortress
Cash FlowStable
Top Statement Risk

Enterprise ERP Competitive Displacement

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Remains Modestly Positive

According to the provided quarterly income statements, HealthStream has maintained a consistent revenue growth trajectory, culminating in a 10.5% year-over-year increase in 2026Q1, which suggests that the company's core subscription-based model continues to benefit from steady, albeit slow, adoption within the domestic healthcare market.

The recent acceleration to double-digit growth in 2026Q1 warrants further investigation to determine if this represents a sustainable shift or a temporary timing benefit from contract renewals. Given the mature nature of the Workforce Solutions segment, investors should monitor whether this growth is driven by new customer acquisition or price increases within the existing installed base.

Structural Gross Margin Stability Observed

As reported in financial statements, HealthStream's gross margin has remained relatively stable, hovering between 63.8% and 66.8% over the last ten quarters, which indicates that the company's cost of service delivery is well-contained despite the ongoing transition toward unified SaaS platform offerings.

The consistency in gross margins suggests that the company possesses a degree of pricing power, likely derived from the regulatory necessity of its accreditation and credentialing tools. However, the lack of significant margin expansion implies that the company has yet to achieve the full economies of scale typically associated with a mature SaaS business model.

Operating Leverage Remains Constrained Historically

Based on the reported figures, the gap between gross profit and operating income has remained wide, with operating margins fluctuating between 3.0% and 9.9%, suggesting that high SG&A and R&D expenses continue to offset the benefits of the company's high-margin subscription revenue streams.

The persistent level of R&D and SG&A spending appears to be a structural requirement to maintain the platform's integration with clinical authorities and to support customer retention. Investors should monitor whether the ongoing consolidation into the 'CredentialStream' platform will eventually allow for a more efficient operating structure and improved profitability.

Earnings Volatility Driven by SBC

Analysis of the income statement reveals that net income has been periodically impacted by stock-based compensation, most notably in 2025Q4 when a $5.4 million charge contributed to a significant compression in net margins, highlighting the influence of non-cash expenses on reported bottom-line performance.

While the company maintains a consistent ability to generate positive net income, the variability in quarterly EPS suggests that investors should focus on normalized earnings metrics to gauge true operational performance. The absence of SBC in 2026Q1 may indicate a shift in compensation strategy that warrants further scrutiny in future filings.

Competitive Risks to Margin Sustainability

While the company's moat appears secure, the potential for enterprise ERP giants to integrate clinical workforce modules into broader HR suites poses a material risk to HealthStream's long-term pricing power and market share, as suggested by the recent competitive context flags in the provided data.

If hospital systems prioritize consolidated HR platforms over specialized clinical tools, HealthStream may face increased pressure to lower prices or increase marketing spend to defend its position. This potential for margin compression remains a key risk that could challenge the current valuation of the company as a stable utility.

HSTM — Frequently Asked Questions

Quick answers to the most common questions about buying HSTM stock.

What was HealthStream, Inc.'s (HSTM) revenue in 2025?

For fiscal year 2025, HealthStream, Inc. (HSTM) reported total revenue of $304.1M. This represents a 11594.8% increase compared to $2.6M in 1999.

Is HealthStream, Inc. (HSTM) profitable?

HealthStream, Inc. (HSTM) is profitable, generating $18.3M in net income for the fiscal year ending 2025 with a net profit margin of 6.0%.

What is HealthStream, Inc.'s operating profit margin?

HealthStream, Inc. (HSTM) reported an operating income of $20.2M, resulting in an operating profit margin of 6.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is HealthStream, Inc.'s gross profit and gross margin?

HealthStream, Inc. (HSTM) generated $196.9M in gross profit for the year, representing a gross profit margin of 64.7%. This demonstrates the company's core pricing power and production efficiency.